A Systematic Review and Meta-Analysis of Cerebrospinal Fluid Amyloid and Tau Levels Identifies Mild Cognitive Impairment Patients Progressing to Alzheimer’s Disease

Reported levels of amyloid-beta and tau in human cerebrospinal fluid (CSF) were evaluated to discover if these biochemical markers can predict the transition from Mild Cognitive Impairment (MCI) to Alzheimer’s disease (AD). A systematic review of the literature in PubMed and Web of Science (April 20...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Yunxing, Brettschneider, Julia, Collingwood, Joanna F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313367/
https://www.ncbi.nlm.nih.gov/pubmed/35885018
http://dx.doi.org/10.3390/biomedicines10071713

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313367/
https://www.ncbi.nlm.nih.gov/pubmed/35885018
http://dx.doi.org/10.3390/biomedicines10071713

Ejemplares similares